U.S. Markets open in 4 hrs 3 mins

Nuvalent, Inc. (NUVL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.60-6.59 (-19.86%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close33.19
Open33.19
Bid26.57 x 3200
Ask26.71 x 1400
Day's Range26.32 - 33.46
52 Week Range17.00 - 40.82
Volume166,167
Avg. Volume305,357
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est42.00
  • PR Newswire

    Nuvalent Announces Business and Program Highlights and Reports Second Quarter 2021 Financial Results

    Nuvalent, Inc., (Nasdaq: NUVL), a biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today reported recent pipeline and business highlights and second quarter 2021 financial results.

  • Barrons.com

    Translate Bio, Nuvalent See Activist Action

    Baupost Group disclosed a large stake in biotech Translate Bio. Bain Capital Life Sciences initiated a big investment in biopharmaceutical firm Nuvalent.

  • PR Newswire

    Nuvalent Announces Closing of Upsized Initial Public Offering

    Nuvalent, Inc., a biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced the closing of its upsized initial public offering of 11,212,500 shares of common stock, consisting of 10,612,500 shares of Class A common stock and 600,000 shares of Class B common stock, which includes 1,462,500 shares of Class A common stock sold pursuant to the exercise in full by the underwriters of their option to purchase additional s